PTO-1390 (01-18)
`Approved for use through 8/31/2019. OMB 0651-0021
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`TRANSMITTAL LETTER TO THE UNITED STATES
`DESIGNATED/ELECTED OFFICE (DO/EO/US)
`CONCERNING A SUBMISSION UNDER 35 U.S.C. 371
`
`gffggnggfie/‘UN;
`US. Application No. (if known, see 37 CFR 1.5)
`
`International Application No.
`PCT/NL2017/050507
`Title of Invention
`
`International Filing Date
`
`Priority Date Claimed
`2016-07-29
`
`PROTEIN-FORTIFIED FOOD PRODUCT
`First Named Inventor
`
`Assié, Martine Elisabeth Marie-Louise
`
`Applicant herewith submits to the United States Designated/Elected Office (DO/EO/US) the following items and other information.
`
`1. E This is an express request to begin national examination procedures (35 U.S.C. 371(f)). NOTE: The express request under
`35 U.S.C. 371(f) will not be effective unless the requirements under 35 U.S.C. 371(c)(1), (2), and (4) for payment ofthe basic
`national fee, copy ofthe International Application and English translation thereof (if required), and the oath or declaration of the
`inventor(s) have been received.
`A copy of the International Application (35 U.S.C. 371(c)(2)) is attached hereto (not required if the lntemational Application was
`previously communicated by the International Bureau or was filed in the United States Receiving Office (RO/US)).
`An English language translation of the International Application (35 U.S.C. 371(c)(2))
`
`. D is attached hereto.
`. D has been previously submitted under 35 U.S.C. 154(d)(4).
`An oath or declaration of the inventor(s) (35 U.S.C. 371(c)(4))
`
`. D is attached.
`b. D was previously filed in the international phase under PCT Rule 4.17(iv).
`Items 5 to 8 below concern amendments made in the international phase.
`PCT Article 19 and 34 amendments
`
`
`
`5. D Amendments to the claims under PCT Article 19 are attached (not required if communicated by the International Bureau)
`(35 U.S.C. 371(c)(3)).
`
`6. B English translation ofthe PCT Article 19 amendment is attached (35 U.S.C. 371(c)(3)).
`
`7. B English translation of annexes (Article 19 and/or 34 amendments only) of the International Preliminary Examination Report is
`attached (35 U.S.C. 371(c)(5)).
`
`Cancellation of amendments made in the international phase
`
`8a. |:| Do not enter the amendment made in the international phase under PCT Article 19.
`
`8b. |:| Do not enter the amendment made in the international phase under PCT Article 34.
`NOTE: A proper amendment made in English under Article 19 or 34 will be entered in the US. national phase application absent a clear
`instruction from applicant not to enterthe amendment(s).
`
`The following items 9 to 17 concern a document(s) or information included.
`
`9. I: An Information Disclosure Statement under 37 CFR 1.97 and 1.98.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`A preliminary amendment.
`
`An Application Data Sheet under 37 CFR 1.76.
`
`A substitute specification. NOTE: A substitute specification cannot include claims. See 37 CFR 1.125(b).
`
`A power of attorney and/or change of address letter.
`
`A computer-readable form ofthe sequence listing in accordance with PCT Rule 13ter.3 and 37 CFR 1.821-1.825 (not required if
`sequence listing in text format was indicated on the PCT Request as part ofthe International Application and the sequence listing
`was published as part ofthe international application).
`
`Assignment papers (cover sheet and document(s)). Name of Assignee:
`
`37 CFR 3.73(c) Statement (when there is an Assignee).
`
`This collection of information is required by 37 CFR 1.414 and 1.491-1.492. The information is required to obtain or retain a benefit by the public, which is to file
`(and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 15
`minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual
`case. Any comments on the amount oftime you require to complete this form and/or suggestions for reducing this burden should be sent to the Chief Information
`Officer, US. Patent and Trademark Office, US. Department of Commerce, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Mail Stop PCT, Commissioner for Patents, PO. Box 1450, Alexandria, VA 22313-1450.
`
`

`

`PTO-1390 (01-18)
`Approved for use through 8/31/2019. OMB 0651-0021
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`us. APPLN. No. (if known — see 37 CFR 1.5)
`INTERNATIONAL APPLICATION No.
`ATTORNEY DOCKET No.
`
`PCT/NL2017/O50507
`
`294-560 PCT/US
`
`17. D Other items or information:
`
`The following fees have been submitted.
`
`18- |E| Basic national fee (37 CFR 1.492(a))
`
`19. E Examination fee (37 CFR 1.492(c))
`.
`lfthe written opinion prepared by ISA/US orthe international preliminary examination report
`prepared by lPEA/US indicates all claims satisfy provisions of PCT Article 33(1)-(4)...
`All othersituations
`
`.. $0
`$760
`
`20. E Search fee (37 CFR 1.492(b))
`lfthe written opinion prepared by ISA/US orthe international preliminary examination report
`.. $0
`prepared by lPEA/US indicates all claims satisfy provisions of PCT Article 33(1)-(4)...
`Search fee (37 CFR 1.445(a)(2)) has been paid on the international application to the USPTO as
`an International Searching Authority$140
`International Search Report prepared by an ISA otherthan the US and provided to the Office or
`previously communicated to the US by the IB .............................................................. $520
`All othersituations$660
`
`.
`
`CALCULATIONS
`
`$ 300
`
`$ 760
`
`E Additional fee for specification and drawings filed in paper over 100 sheets (excluding sequence listing
`in compliance with 37 CFR 1.821 (c) or (e) in an electronic medium or computer program listing in an
`electronic medium) (37 CFR 1.492(j)).
`
`TOTAL OF 18, 19, and 20 = $1,580
`
`$400
`
`
`
`Fee for each additional 50 sheets of paper orfraction thereof
`Number of each addItIonal 50 or fractIon
`thereof (round up to a whole number)
`
`Extra Sheets
`
`Total Sheets
`
`Surcharge for furnishing any of the search fee, examination fee, or the oath or declaration after the date of
`commencement ofthe national stage (37 CFR1492(h))$140
`CLAIMS
`NUMBER FILED
`NUMBER EXTRA
`
`Independent claims
`
`MULTIPLE DEPENDENT CLA|M(S) (if applicable)
`
`Fee for submission of Sequence Listing text file of 300 MB to 800 MB (37 CFR 1.21(o)(1)) ................... $1,000
`
`Fee for submission of Sequence Listing text file ofmore than 800 MB (37 CFR 1.21(o)(2))...
`
`..........$10,000
`
`Processing fee for furnishing the English translation later than 30 months from the earliest claimed priority date
`
`TOTAL OF ABOVE CALCULATIONS —
`I: Applicant asserts small entity status. See 37 CFR 1.27. Fees above are reduced by 1/2.
`Applicant certifies micro entity status. See 37 CFR 1.29. Fees above are reduced by %.
`Applicant must attach form PTO/SB/15A or B or equivalent.
`
`$ 1 ,720
`
`TOTAL NATIONAL FEE =
`
`Fee for recording the enclosed assignment (37 CFR 1.21 (h)). The assignment must be accompanied by an
`appropriate cover sheet (37 CFR 3.28, 3.31) ........................................................ $50.00 per property
`
`+
`
`[Page 2 of 3]
`
`

`

`PTO-1390 (01-18)
`Approved for use through 8/31/2019. OMB 0651-0021
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`D A check in the amount of $
`
`to cover the above fees is enclosed.
`
`Please charge my Deposit Account No.
`
`in the amount of $
`
`to cover the above fees.
`
`The Director is hereby authorized to charge additional fees which may be required, or credit any overpayment, to Deposit Account
`No.
`0872461
`as follows:
`
`E any required fee.
`
`IEI any required fee except for excess claims fees required under 37 CFR 1.492(d) and (e) and multiple dependent claim fee
`required under 37 CFR1.492(f).
`Fees are to be charged to a credit card. WARNING:
`lnfonnation on this form may become public. Credit card information should not
`be included on this form. Provide credit card information and authorization on PTO-2038. The PTO-2038 should only be mailed or
`faxed to the USPTO. However, when paying the basic national fee, the PTO-2038 may NOT be faxed to the USPTO.
`
`If filing by EFS-Web, do NOT attach the PTO-2038 form as a PDF along with your EFS-Web submission. Please be
`ADVISORY:
`advised that this is not recommended and by doing so your credit card information may be displayed via PAIR. To protect your
`information, it is recommended to pay fees online by using the electronic payment method.
`
`NOTE: Where an appropriate time limit under 37 CFR 1.495 has not been met, a petition to revive (37 CFR 1.137(a) or (b)) must be
`filed and granted to restore the International Application to pending status.
`
`IEI The address associated with Customer Number:
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition Applications
`
`D This application (1) claims priority to or the benefit of an application filed before March 16, 2013, and (2) also contains, or contained at
`any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013.
`NOTE 1: By providing this statement under 37 CFR1.55 or 1.78, this application, with a filing date on or after March 16I 2013I will be
`examined under the first inventor to file
`rovisions of the AIA.
`
`NOTE 2: A US. national stage application may not claim priority to the international application of which it is the national phase. The filing
`date of a US. national stage application is the international filing date. See 35 U.S.C. 363.
`
`Correspondence Address
`
`2—3869 OR
`
`I: Correspondence address below
`
`I—
`I—
`II-——_
`--——
`I—
`
`-/linda cl. chin/
`Linda D. Chin
`
`.2019-01-25
`58,205
`
`[Page 3 of 3]
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission ofthe attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised that: (1) the general authority forthe collection of this information is 35 U.S.C. 2(b)(2); (2)
`furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the
`US. Patent and Trademark Office is to process and/or examine your submission related to a patent application or
`patent.
`If you do not furnish the requested information, the US. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or abandonment of the
`application or expiration ofthe patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1 . The information on this form will be treated confidentially to the extent allowed underthe Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may
`be disclosed to the Department ofJustice to determine whether disclosure of these records is required by the
`Freedom of Information Act.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from
`the Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor ofthe Agency having
`need forthe information in orderto perform a contract. Recipients of information shall be required to comply
`with the requirements ofthe Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed underthe Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(0)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part ofthat agency’s
`responsibility to recommend improvements in records management practices and programs, under authority of
`44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records forthis purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public ifthe record
`was filed in an application which became abandoned or in which the proceedings were terminated and which
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`